Envision Healthcare (EVHC) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Envision Healthcare Reports 2017 Fourth Quarter Financial Results
February 27, 2018 4:19 PM ESTIntroduces 2018 Financial Guidance
Review of Strategic Alternatives is Ongoing
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Envision Healthcare Corporation (Envision) (NYSE: EVHC) today reported financial results for the three and 12 months ended December 31, 2017, that exceeded its most recent Adjusted EBITDA and Adjusted earnings per share guidance.
Highlights for the fourth quarter of 2017 include:
Net revenue from continuing operations of $2.00 billion; Net earnings from continuing operations attributable to common stockholders of $137.8 million or $1.13 per diluted share; Adjusted net earnings from continuing... More


